Design of Peptide Analogues with Improved Activity Using a Novel de Novo Protein Design Approach

2004 ◽  
Vol 43 (14) ◽  
pp. 3817-3826 ◽  
Author(s):  
J. L. Klepeis ◽  
C. A. Floudas ◽  
D. Morikis ◽  
C. G. Tsokos ◽  
J. D. Lambris
2021 ◽  
Vol 18 (3) ◽  
pp. 233-233
Author(s):  
Arunima Singh

1997 ◽  
Vol 273 (4) ◽  
pp. 789-796 ◽  
Author(s):  
Bassil I Dahiyat ◽  
Catherine A Sarisky ◽  
Stephen L Mayo

1994 ◽  
Vol 22 (4) ◽  
pp. 1033-1036
Author(s):  
A. Berry ◽  
S. E. Brenner

2008 ◽  
Vol 94 (2) ◽  
pp. 584-599 ◽  
Author(s):  
Ho Ki Fung ◽  
Christodoulos A. Floudas ◽  
Martin S. Taylor ◽  
Li Zhang ◽  
Dimitrios Morikis

Author(s):  
Jeffrey R. Brender ◽  
David Shultis ◽  
Naureen Aslam Khattak ◽  
Yang Zhang

2020 ◽  
Vol 7 (8) ◽  
pp. 1410-1412
Author(s):  
Weijie Zhao ◽  
Chu Wang

Abstract Search ‘de novo protein design’ on Google and you will find the name David Baker in all results of the first page. Professor David Baker at the University of Washington and other scientists are opening up a new world of fantastic proteins. Protein is the direct executor of most biological functions and its structure and function are fully determined by its primary sequence. Baker's group developed the Rosetta software suite that enabled the computational prediction and design of protein structures. Being able to design proteins from scratch means being able to design executors for diverse purposes and benefit society in multiple ways. Recently, NSR interviewed Prof. Baker on this fast-developing field and his personal experiences.


Sign in / Sign up

Export Citation Format

Share Document